Gross Profit On Sales Veränderung Datum
Adma Biologics USD 31.09M 6.43M 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Dynavax Technologies USD 46.91M 9.38M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Heron Therapeutics USD 13.23M 1.62M 2023-09
Insmed USD 65.25M 2.88M 2023-12
Knight Therapeutics CAD 40.18M 2.69M 2023-09
Omeros USD 29.67M 1.19M 2021-09
Pacira USD 133.55M 9.38M 2023-12
Pfizer USD 7.58B 3.26B 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
United Therapeutics USD 543.7M 4.4M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Omeros Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.